Leaderboards/Vascular Tumors and Angiosarcomas

Vascular Tumors and Angiosarcomas

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Papers

TFEB drives mTORC1 hyperactivation and kidney disease in Tuberous Sclerosis Complex

Nature Communications|2024

45 cit.

Beyond the barrier: the immune-inspired pathways of tumor extravasation

Cell Communication and Signaling|2024

24 cit.

Dysfunctional mechanotransduction regulates the progression of PIK3CA-driven vascular malformations

APL Bioengineering|2025

6 cit.

NF-κB-mediated cytokine secretion and glutamate metabolic reprogramming converge in breast cancer brain tropism

Cancer Letters|2025

6 cit.

Publication in Clinical Cancer Research (2025) [5 citations, W4412118479]

Clinical Cancer Research|2025

5 cit.

Phase II Trial of Axicabagene Ciloleucel and Glofitamab As Second-Line Therapy for Patients with Relapsed or Refractory Large B-Cell Lymphoma

Blood|2024

4 cit.

Publication in Clinical & Experimental Immunology (2024) [4 citations, W4405307461]

Clinical & Experimental Immunology|2024

4 cit.

Publication in Journal of Clinical Oncology (2024) [3 citations, W4399605413]

Journal of Clinical Oncology|2024

3 cit.

Publication in Blood Cancer Journal (2025) [1 citation, W4406274499]

Blood Cancer Journal|2025

1 cit.

Publication in ESMO Open (2024) [W4392888823]

ESMO Open|2024

0 cit.

Emerging Leaders

Drafting the new consensus

Papers

A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma

Nature Cancer|2024

56 cit.

Sarculator is a Good Model to Predict Survival in Resected Extremity and Trunk Sarcomas in US Patients

Annals of Surgical Oncology|2022

54 cit.

Uterine Inflammatory Myofibroblastic Tumors

The American Journal of Surgical Pathology|2022

32 cit.

Progression of Low-Grade Neuroendocrine Tumors (NET) to High-Grade Neoplasms Harboring the NEC-Like Co-alteration of RB1 and TP53

Endocrine Pathology|2024

32 cit.

MEK inhibition reduced vascular tumor growth and coagulopathy in a mouse model with hyperactive GNAQ

Nature Communications|2023

30 cit.

Comparison of clonal architecture between primary and immunodeficient mouse-engrafted acute myeloid leukemia cells

Nature Communications|2022

28 cit.

Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in <i>CTNNB1</i> or <i>APC</i> : A Multi-institutional Retrospective Study

Clinical Cancer Research|2022

28 cit.

NRASQ61R mutation in human endothelial cells causes vascular malformations

Angiogenesis|2022

25 cit.

Randomized phase II trial of cabozantinib combined with PD-1 and CTLA-4 inhibition versus cabozantinib in metastatic soft tissue sarcoma.

Journal of Clinical Oncology|2023

21 cit.

Botensilimab (Fc-enhanced anti–cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti–PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas

Journal of Clinical Oncology|2025

20 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

Christopher D.�M. Fletcher

Brigham and Women's Hospital

Kari Alitalo

University of Helsinki

Sharon W. Weiss

Tel Aviv University

Jean‐Yves Blay

Université Claude Bernard Lyon 1

Napoleone Ferrara

Unknown

Cristina R. Antonescu

Memorial Sloan Kettering Cancer Center

Murray F. Brennan

Memorial Sloan Kettering Cancer Center

Mayo Clinic in Arizona

Papers

A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?

Cell|2011

7.7k cit.

Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen

Science|1989

5k cit.

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

Nature|1993

3.6k cit.

World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone

Lund University Publications (Lund University)|2002

2.8k cit.

Two Hundred Gastrointestinal Stromal Tumors

Annals of Surgery|2000

2.5k cit.

A coding-independent function of gene and pseudogene mRNAs regulates tumour biology

Nature|2010

2.4k cit.

Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells

Biochemical and Biophysical Research Communications|1989

2.3k cit.

A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules

The Journal of Experimental Medicine|2015

2.2k cit.

The histogenesis and biologic behavior of primary human malignant melanomas of the skin.

PubMed|1969

2.1k cit.

Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction Pathway

Journal of Biological Chemistry|1998

2k cit.

Reagents for Vascular Tumors and Angiosarcomas

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling Technology

C-Peptide Antibody

#4593$317

View Evidence →

Cell Signaling TechnologyEvidence 60

Cyclin Antibody Sampler Kit

#9869$722

View Evidence →

Cell Signaling TechnologyEvidence 65

NFAT1 Antibody

#4389$317

View Evidence →

🌟 All-Time

Most validated

D2-40

Cell Signaling Technology

Phospho-WIPI2 (Ser413) Antibody

Cited in 5 papers

#13571$362

View Evidence →

Cell Signaling TechnologyEvidence 66

Phospho-Histone H3 (Thr3) (D5G1I) Rabbit Monoclonal Antibody

Cited in 5 papers

#13576$176,415

View Evidence →